openPR Logo
Press release

Norman Paradis, MD joins Oran Diagnostics as Acting Chief Medical Officer

12-14-2010 10:02 AM CET | Health & Medicine

Press release from: LearnWell

BERWYN, PA, NOVEMBER 15TH, 2010—Oran Diagnostics, LLC, a specialized medical device company developing novel clinical diagnostic tools for applications across a broad spectrum of disease states, today announced that Norman A. Paradis, MD has joined the Company as Acting Chief Medical Officer. Dr. Paradis will be responsible for providing the Company guidance in clinical trial design, regulatory submissions, new product development and product strategy and positioning.

Dr. Paradis is a recognized leader in the medical device and molecular diagnostics arena. He has led medical, clinical and research teams working in both diagnostics and therapeutics; including biomarkers, cardiovascular devices, ischemia-reperfusion, and sepsis, and immunodiagnostics. Dr. Paradis’ experience makes him exceptionally well suited to assist in the development and commercialization of the TCL Analyzer ™, Oran’s innovative platform technology with potential applications across multiple clinical specialties. Dr. Paradis was previously Vice-President of Clinical and Medical Affairs at Biosite Inc. (now Inverness), where he built teams that designed and initiated more than a dozen clinical trials in molecular biomarkers. Subsequently he served as Vice President and Chief Medical Officer at Cylex Inc.

Prior to entering the private sector, Dr. Paradis served as Professor of surgery and medicine at the University of Colorado, and Senior Medical Director of emergency medicine at University of Colorado Hospital from 1999 to 2005, where he headed a research group with active programs in real-time diagnostic technology, hemodynamics, hypothermia, stroke biomarkers, fibrinolytics and emergency cardiopulmonary bypass. He is an acting Co-Director of the Colorado Emergency Medicine Research Center. Dr. Paradis has also held clinical, academic and administrative positions at Columbia University, New York University and Medical College of Virginia. He has been a member of numerous medical professional organizations, including the Society for Academic Emergency Medicine (SAEM), Society of Critical Care Medicine (SCCM), the American College of Emergency Medicine (ACEP), and the American Academy of Emergency Medicine (AAEM) among others. Dr. Paradis was one of the founding members of SAEM's Reperfusion Working Group, and has been active in the American Heart Association (AHA), serving on the Advanced Cardiac Life Support (ACLS) Subcommittee for more than 10 years. He is also a fellow of the American Board of Emergency Medicine. Dr. Paradis is on the editorial boards of The American Journal of Emergency Medicine, Resuscitation, and the Critical Illness section of the Journal of the American Medical Association (JAMA). He has published more than 50 papers in cardiology, critical care and emergency medicine journals as well as being the senior editor of Cardiac Arrest-The Science and Practice of Resuscitation Medicine. Dr. Paradis trained in emergency medicine at the University of Southern California (USC) and completed a research fellowship at Henry Ford Hospital. He received his B.S. with Highest Honors in Molecular Biology from Marlboro College and earned his M.D. from Northwestern University.

About Oran Diagnostics

Oran Diagnostics, LLC is using its proprietary device (the TCL Analyzer ™) and method (thermochemiluminescence) to develop accurate, minimally invasive clinical tools for use in clinical diagnostics, and for drug discovery and development. The company’s proprietary technology is currently being applied in cardiovascular and neurodegenerative disease. Oran Diagnostics is headquartered in Berwyn, PA, with research and development facilities in Haifa, Israel. For more information, please visit

TCL-HF™ is a rapid, minimally invasive procedure for designed to aid in the risk stratification of patients diagnosed with heart failure. The TCL Analyzer™ measures lipid peroxidation in a small sample (50 microlitres) of blood serum. Using a highly sensitive, proprietary method of biomarker identification (thermochemiluminescence), TCL-HF™ measures the level of oxidative stress and oxidizability, which measurement correlates with the degree of disease severity. Analysis can be performed in a hospital or clinical laboratory in just minutes. TCL-HF™ provides a relevant, previously unavailable clinical data point that helps guide treatment options for patients with heart failure. The TCL Analyzer™ and TCL-HF™ are not currently cleared for use in the U.S. by the Food and Drug Administration.

Contact: Meredith Hegg
491 Baltimore Pike Suite 209
Springfield, PA 19064
Phone: 610-626-0175

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Norman Paradis, MD joins Oran Diagnostics as Acting Chief Medical Officer here

News-ID: 155263 • Views: 935

More Releases from LearnWell

Bill Ringle Interviews Business Sales Expert Mark Satterfield on My Quest for Be …
Bill Ringle, America’s Business Growth Strategist, talked with Mark Satterfield, CEO of Gentle Rain Marketing, for the interview show My Quest for the Best. Philadelphia, PA, May 06, 2012 - Business growth strategist Bill Ringle interviewed Mark Satterfield, CEO of Gentle Rain Marketing and author of Unique Sales Stories, for My Quest for the Best. In this interview series, Ringle speaks with successful industry experts and outstanding business leaders about their
Oran Diagnostics Adds Reproductive Health to License Agreement with Carmel Diagn …
BERWYN, PA, February 14, 2011. Oran Diagnostics, LLC, a privately held diagnostics company, today announced that it has expanded its exclusive worldwide license agreement with Carmel Diagnostics, Ltd. of Kiryat Tivon, Israel, to include reproductive health. This expansion into reproductive medicine enables Oran to continue development of TCL-EV™, a rapid, non-invasive procedure that can be used to identify embryos with the greatest reproductive potential in patients undergoing IVF. TCL-EV™ is
Greater Philadelphia Business Owners Gather to Find Out How to “Become Famous …
Philadelphia, PA - January 14, 2011 - On January 11, 2011, Bill Ringle, founder of Rainmaker Academy, partnered with the Baiada Center at Drexel University to lead a half-day session titled “Become Famous In Your Niche so Business Comes to You”. Ringle led a full room of entrepreneurs and business owners through tips, insights and practical lessons in business development and marketing. While navigating topics such as defining your
Todd Wallach and Paul Sohmer, MD join Oran Diagnostics’ Board of Managers
BERWYN, PA, October 1, 2010—Oran Diagnostics, LLC, a specialized medical device company developing novel clinical diagnostic tools for applications across a broad spectrum of disease states, today announced that Todd Wallach and Paul Sohmer, MD have joined the Company’s Board of Managers. Mr. Wallach is the Chairman and Chief Executive Officer of Molecular Detection, Inc. (MDI). MDI is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready™ molecular diagnostic tests for the

All 5 Releases

More Releases for Paradis

The Internet is down and it’s not my fault.
NutPile Networks creates software that eliminates hours of frustrating tech support calls, gives users proof of what is happening with their Internet connection. PRESCOTT, AZ – How many times can you reboot a router before you give up in frustration? That’s the question Mike Paradis, NutPile Network’s creator, asked himself a few years ago. Despite paying for an expensive business package with a local cable Internet provider, he found himself spending
Champagne Supermoon
(BOSTON, MA) This fall, the solar system is giving us one of its best live shows: a series of stunning supermoons, visible during the month of October, November and December 2016. In celebration, The Beehive, Boston’s hotspot in the buzzing South End, is continuing its popular Champagne Supermoon special. With a sellout crowd on October 16th, The Beehive will once again be opening up its Champagne cellar and offering guests
Voyage Inde du sud, Vacance, Circuit Inde du sud, Kerala | Jodhpur Voyage
Sud de l’Inde Un voyage qui sera comme un massage Ayurvedic dans le Sud de l’Inde. Vous ne pouvez pas dire que je l’ai vraiment vu l’Inde si vous avez vécu dans le sud de l’Inde. Quel est le temple hindou le plus fascinant de l’Inde? Pour Madurai, dans le Tamil Nadu. Où sont temple le plus spectaculaire de la ville, Au Tamil Nadu, qui est également le foyer du théâtre
GOLFINO celebrates 25th anniversary
Glinde, 8 March 2011 – “25 Years of Elegance in Sport” – with this motto, GOLFINO AG is celebrating its anniversary in 2011. For a quarter of a century, GOLFINO has been providing its sophisticated customers with exclusive sportswear, which combines high-tech functionality with an elegant, sporting style. The company was founded in 1986 and has continuously grown to become the European market leader for golfwear. In March, the 25th
Johnny Depp, The Tourist, buys Palace in Venice, Italy
Actor Johnny Depp, whose recent films include The Tourist, has bought the Palazzo Donà Sangiantoffetti Palace in Venice, Italy for a reported US$ 13.8 million. The forty seven year old actor apparently fell in love with Venice last year whilst filming The Tourist with co-star Angelina Jolie. According to local newspaper La Nuova Venezia, the Hollywood star outbid an Arab prince for the empty property. The seventeenth century Palazzo Donà Sangiantoffetti was one
Le Paradis du Fromage – Distributing cheese worldwide with abas Business Softw …
Lyon, France / Karlsruhe, Germany, January 26th, 2009 – French cheese manufacturer and global distributor Fromi Groupe will implement abas Business Software (ERP, PPC, MRP, eBusiness). Synchronizing different branches and warehouses throughout the world, simplifying their administration, and increasing global sales are the expectations of Fromi Groupe about their new ERP software. French cheese manufacturer FROMI Groupe will implement abas ERP When it comes to cheese, is quality FROMI’s first priority. Their